Falsified Medicines Directive (FMD) Decommissioning of 2D bar-codes

With the advent of the Falsified Medicines Directive (EU2011/62) and Delegated Regulation 2016/161, Pharmaconsulta has positioned itself as a leader in compliance and innovation. We were among the first to adopt these critical regulations, ensuring full compliance with the European Medicines Verification System (EMVS) and the Malta Medicines Verification Organization (MAMVO). Our extensive expertise allows us to offer comprehensive assistance with the setup and maintenance of EMVS and MAMVO verification and decommissioning structures. This includes establishing robust systems for verifying the authenticity of medicinal products and effectively managing decommissioning processes. 

Moreover, Pharmaconsulta provides third-party decommissioning and verification services, ensuring that your operations remain compliant without the need for significant in-house infrastructure. Our services are designed to safeguard the supply chain against falsified medicines, protecting both patient safety and your company’s reputation. By partnering with Pharmaconsulta, you benefit from our pioneering experience and dedicated support, ensuring seamless integration and ongoing compliance with the latest EU directives. Our commitment to staying ahead of regulatory changes means that you can focus on your core business activities, confident in the knowledge that your compliance needs are met with the highest standards of excellence.